amyotrophic lateral sclerosis type 20

ICD-10 Codes

Related ICD-10:

Description

Amyotrophic Lateral Sclerosis (ALS) Type 20, also known as HNRNPA1 ALS, is a rare and specific subtype of ALS.

Characteristics

  • This form of ALS is caused by a mutation in the HNRNPA1 gene on chromosome 12 [7].
  • It is characterized by juvenile onset, meaning it typically affects individuals at a younger age compared to other forms of ALS [8].

Key Features

  • Progressive muscular paralysis due to degeneration of motor neurons in the primary motor cortex, corticospinal tracts, and spinal cord [6].
  • The disorder is named for its underlying cause, which involves a mutation in the HNRNPA1 gene.

Genetic Basis

  • ALS20 is associated with a specific genetic mutation in the HNRNPA1 gene, making it a distinct subtype of ALS [7].

References

[7] - This form of ALS is caused by a mutation in the HNRNPA1 gene on chromosome 12. [6] - Progressive muscular paralysis due to degeneration of motor neurons in the primary motor cortex, corticospinal tracts, and spinal cord. [8] - It is characterized by juvenile onset, meaning it typically affects individuals at a younger age compared to other forms of ALS.

Additional Characteristics

  • Progressive muscular paralysis due to degeneration of motor neurons in the primary motor cortex, corticospinal tracts, and spinal cord.
  • Juvenile onset, meaning it typically affects individuals at a younger age compared to other forms of ALS.
  • Caused by a mutation in the HNRNPA1 gene on chromosome 12.

Signs and Symptoms

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative condition that affects the nerve cells responsible for controlling voluntary muscle movement. The symptoms of ALS can vary from person to person, but there are some common signs and symptoms associated with this disease.

Common Symptoms:

  • Weakness or Spasticity: ALS typically announces itself with persistent weakness or spasticity in an arm or leg (80% of all cases), causing difficulty using the affected limb [2].
  • Twitching and Cramping: Twitching and cramping of muscles, especially those in the hands and feet are common symptoms of ALS [4].
  • Loss of Motor Control: Loss of motor control in the hands and arms is another symptom associated with ALS [4].
  • Trouble Walking or Doing Daily Activities: Trouble walking or doing usual daily activities due to muscle weakness can be a sign of ALS [1].

Other Symptoms:

  • Hand Weakness or Clumsiness: Hand weakness or clumsiness can also be a symptom of ALS [1].
  • Slurred Speech: Slurred speech is another early symptom that may occur in some people with ALS [8].
  • Muscle Cramps and Twitches: Muscle cramps and twitches, especially in the hands and feet, are common symptoms of ALS [7].

Early Symptoms:

  • Clumsiness: Clumsiness or unusual limb fatigue can be an early symptom of ALS [8].
  • Unusual Limb Fatigue: Unusual limb fatigue is another early symptom that may occur in some people with ALS [8].

It's essential to note that not all people with ALS experience the same symptoms, and the progression of the disease can vary from person to person. If you or someone you know is experiencing any of these symptoms, it's crucial to consult a healthcare professional for proper diagnosis and treatment.

References: [1] - Symptoms · Trouble walking or doing usual daily activities. · Tripping and falling. · Weakness in the legs, feet or ankles. · Hand weakness or clumsiness. · Slurred ... [2] - ALS typically announces itself with persistent weakness or spasticity in an arm or leg (80% of all cases), causing difficulty using the affected limb. [4] - What are the symptoms of ALS? · Twitching and cramping of muscles, especially those in the hands and feet · Loss of motor control in the hands and arms · Trouble ... [7] - by A Verma · 2021 · Cited by 22 — Fascicular twitching and cramping are common. PMA typically differs from classical ALS in diminished or absent tendon reflexes and undetectable clinical signs ... [8] - Early symptoms often include clumsiness, unusual limb fatigue, muscle cramps and twitches, and slurred speech. A person experiences symptoms throughout their ...

Additional Symptoms

  • Clumsiness
  • Weakness or Spasticity
  • Twitching and Cramping
  • Loss of Motor Control
  • Trouble Walking or Doing Daily Activities
  • Muscle Cramps and Twitches
  • Unusual Limb Fatigue
  • hand weakness
  • slurred speech

Diagnostic Tests

Diagnostic Tests for Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurological disease that affects the nerve cells in the brain and spinal cord. Diagnosing ALS can be challenging, as there is no single test that can definitively confirm the condition.

Common Diagnostic Tests for ALS

Several tests are used to diagnose ALS, including:

  • Electromyography (EMG): This test measures the electrical activity of muscles to detect abnormal muscle contractions and relaxations. [6]
  • Nerve Conduction Study: This test measures the speed and strength of electrical signals traveling through nerves. [3]
  • MRI: Magnetic Resonance Imaging can help rule out other conditions that may be causing symptoms similar to ALS. [4]
  • Muscle and Nerve Biopsies: These tests involve taking a sample of muscle or nerve tissue for examination under a microscope. [3]
  • Spinal Tap: This test involves withdrawing a sample of cerebrospinal fluid from the spine to check for abnormal protein levels. [4]
  • Genetic Tests: Some people with ALS may have genetic mutations that can be detected through genetic testing. [7]

Other Diagnostic Criteria

In addition to these tests, healthcare providers also use clinical criteria to diagnose ALS. The "El Escorial" criteria are widely accepted and involve a combination of symptoms and test results to confirm the diagnosis. [1]

Laboratory Tests

While laboratory tests can help rule out other conditions, they generally do not provide definitive evidence of ALS. Blood tests, urine tests, and other laboratory tests may be performed to rule out other disease processes. [5][8]

It's essential to note that a diagnosis of ALS is typically made by a healthcare provider based on a combination of these tests and clinical criteria.

References:

[1] Aug 20, 2021 — The most widely accepted benchmarks for assessing whether a person has ALS are known as the “El Escorial” criteria. [Context #1]

[3] Feb 13, 2023 — What tests are used to diagnose ALS? · Nerve conduction study · Electromyography · MRI · Muscle and nerve biopsies · Spinal tap · Genetic tests · Other ... [Context #3]

[4] Feb 28, 2023 — An ALS diagnosis usually involves various tests, including testing the nerves, blood tests, spinal tap, X-rays, and neurological exams. A person ... [Context #4]

[5] Apr 11, 2024 — Laboratory tests are performed primarily to rule out other disease processes; results generally are normal in ALS. [Context #5]

[6] What tests diagnose ALS? You'll need several tests to confirm an ALS diagnosis, including: Blood tests. Urine tests. Electromyogram (EMG) to measure the ... [Context #6]

[7] by H Mitsumoto · 1997 · Cited by 75 — Diagnostic tests, such as electromyography (EMG), neuroimaging, blood and urine tests and, if indicated, muscle and nerve biopsy, are therefore used in this ... [Context #7]

[8] Apr 11, 2024 — ALS may be diagnosed in a patient with acquired, progressive weakness by showing either (a) UMN+LMN findings in one limb or (b) LMN findings in ... [Context #8]

Additional Diagnostic Tests

  • MRI
  • Electromyography (EMG)
  • Genetic Tests
  • Spinal Tap
  • Muscle and Nerve Biopsies
  • Nerve Conduction Study

Treatment

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. While there is no cure for ALS, several drug treatments have been approved to manage its symptoms and slow down disease progression.

Approved Drug Treatments:

  • Riluzole: The only FDA-approved medication that has shown efficacy in extending life in ALS patients [3][5]. Riluzole works by blocking the release of glutamate, a neurotransmitter that can be toxic to nerve cells at high levels. By reducing glutamate release, riluzole may help slow down disease progression and extend survival [1][2].
  • Edaravone: Another FDA-approved medication for ALS, edaravone has been shown to reduce the rate of decline in patients with ALS [6][7]. Edaravone is thought to work by reducing oxidative stress and inflammation in the brain.

Other Experimental Treatments:

  • Several other drugs are being investigated as potential treatments for ALS, including methylcobalamin, masitinib, AMX0035, CNM-Au8, and tofersen [8]. These experimental treatments have shown promise in clinical trials, but more research is needed to confirm their efficacy.

Current Treatment Landscape:

  • Unfortunately, there are no disease-modifying treatments available for ALS that can halt or reverse the disease process. However, with proper care and management, patients with ALS can lead active and fulfilling lives [6].

References:

[1] by H Lu · 2016 · Cited by 70 [2] by P Hoxhaj · 2023 · Cited by 10 [3] Apr 11, 2024 [5] Apr 11, 2024 [6] Aug 23, 2018 [7] There are 2 FDA-approved medications shown to modify the disease course of ALS: riluzole, and edaravone (Table 1). [8] by JS Jiang · 2022 · Cited by 50

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Amyotrophic Lateral Sclerosis (ALS) type 2, also known as familial ALS, can be challenging to diagnose due to its similarity with other neurodegenerative disorders. However, there are several key factors that can help differentiate it from other conditions.

Differential Diagnoses:

  • Frontotemporal Dementia (FTD): ALS and FTD often form a clinical continuum, where progressive language deficits or behavioral changes are present in addition to motor symptoms. [4]
  • Kennedy's Disease: This is a multisystem disorder characterized by features of sexual dysfunction, dysmetabolism, urinary problems, and muscle weakness, which can be similar to ALS. However, Kennedy's disease typically progresses more slowly than ALS. [2]
  • ALS Mimic Syndromes: These are unrelated disorders that may have a similar presentation to ALS, such as:
    • Progressive Muscular Atrophy (PMA): A rare condition characterized by progressive muscle weakness and wasting.
    • Spinal Muscular Atrophy (SMA): A genetic disorder affecting the nerve cells responsible for controlling voluntary muscle movement.
    • Myasthenia Gravis: An autoimmune disease causing muscle weakness and fatigue.

To diagnose ALS type 2, clinicians use a combination of:

  1. Clinical evaluation: Assessing symptoms, medical history, and physical examination findings.
  2. Imaging studies: Using MRI or CT scans to rule out other conditions affecting the brain or spinal cord.
  3. Electrophysiological tests: Conducting EMG or nerve conduction studies to evaluate muscle and nerve function.
  4. Genetic testing: Identifying specific genetic mutations associated with familial ALS.

The revised El Escorial criteria, Awaji criteria, and Gold Coast criteria are used to diagnose ALS, taking into account the presence of upper motor neuron signs, lower motor neuron signs, and other clinical features. [8]

It's essential to note that a definitive diagnosis of ALS can only be made by excluding other potential causes of muscle weakness or wasting.

References:

[2] de Carvalho, M. (2023). Kennedy's Disease: A Multisystem Disorder. [Context 2]

[4] de Carvalho, M. (2024). ALS and Frontotemporal Dementia: A Clinical Continuum. [Context 4]

[8] Feldman, E. L. (2022). Criteria for Diagnosing Amyotrophic Lateral Sclerosis. [Context 8]

Note: The numbers in square brackets refer to the context numbers provided.

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_1237
owl#annotatedSource
t336625
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#creation_date
2014-09-16T15:34:12Z
oboInOwl#id
DOID:0060211
oboInOwl#created_by
emitraka
oboInOwl#hasDbXref
MIM:615426
oboInOwl#hasExactSynonym
amyotrophic lateral sclerosis 20
IAO_0000115
An amyotrophic lateral sclerosis with juvenile onset that has_material_basis_in mutation in the HNRNPA1 gene on chromosome 12.
relatedICD
http://example.org/icd10/G23.2
core#notation
DOID:0060211
rdf-schema#label
amyotrophic lateral sclerosis type 20
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_332
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.